15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis-Reference-Cited by-同舟云学术

15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis

Published:2024-02 Issue: Volume:68 Page:102413
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Paravathaneni Mahati,Safa Houssein,Joshi Vidhu,Tamil Monica K.,Adashek Jacob J.^ORCID,Ionescu Filip,Shah Savan^ORCID,Chadha Juskaran S.,Gilbert Scott,Manley Brandon,Semaan Adele,Jim Heather S.L.,Kalos Denise,Kim Youngchul,Spiess Philippe E.,Chahoud Jad^ORCID

Publisher

Elsevier BV

Reference47 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

2. Updated European Association of Urology Guidelines: recommendations for the treatment of first-line metastatic clear cell renal cancer;Powles;Eur Urol,2018

3. Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology;Flaig;J Natl Compr Cancer Netw,2020

4. Immune checkpoint inhibitors in the treatment of renal cell carcinoma;Parikh;Semin Nephrol,2020

5. Treatment beyond progression in patients with advanced renal cell carcinoma treated with nivolumab in CheckMate 025;Escudier;Eur Urol,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patientenberichtete Endpunkte – die Bedeutung der subjektiven Patientenperspektive für Forschung und klinische Versorgung;Die Urologie;2024-08-07

2. Perceptions and Expectations: A Study on Prognostic Perception and Quality of Life in Patients With Metastatic Renal and Bladder Cancer;JCO Global Oncology;2024-08

3. Medical Statistics in Drug Development and Regulatory Approval;Advances in Bioinformatics and Biomedical Engineering;2024-07-18

4. Feasibility of a Smartphone Application for Education and Symptom Management of Patients With Renal Cell Carcinoma on Combined Tyrosine Kinase and Immune Checkpoint Inhibitors;JCO Clinical Cancer Informatics;2024-07

5. The quality of life assessment of breast cancer patients;Breast Disease;2024-06-11